Literature DB >> 7805686

Evaluation of an oligonucleotide probe and an immunological test for direct detection of toxigenic Clostridium difficile in stool samples.

G A Green1, B Riot, H Monteil.   

Abstract

A 33 basepair oligonucleotide probe, designed from the sequence of the Clostridium difficile toxin B gene, was evaluated for its ability to detect toxigenic Clostridium difficile directly in stool samples, without culture or DNA isolation. Two different labelling techniques were investigated: radiolabelling and digoxigenin-labelling. One hundred ninety-six stools were tested, with a good correlation (96%) obtained between the oligonucleotide probe and the gold standard, the cytotoxicity tissue culture assay. The sensitivity and specificity were 83% and 100%, respectively. In parallel, a new commercially available enzyme immunoassay for the detection of Clostridium difficile toxin A in stool specimens was investigated. In 162 samples tested, a sensitivity of 80% and a specificity of 98% were obtained.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7805686     DOI: 10.1007/bf01971309

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  Evaluation of a commercial enzyme immunoassay kit for the detection of Clostridium difficile toxin A.

Authors:  S P Borriello; T Vale; J S Brazier; S Hyde; E Chippeck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

2.  Non-radioactively labelled polynucleotide and oligonucleotide DNA probes, for selectively detecting Escherichia coli strains producing Vero cytotoxins VT1, VT2 and VT2 variant.

Authors:  A Thomas; H R Smith; G A Willshaw; B Rowe
Journal:  Mol Cell Probes       Date:  1991-04       Impact factor: 2.365

3.  Multicenter evaluation of a new enzyme immunoassay for detection of Clostridium difficile enterotoxin A.

Authors:  P C De Girolami; P A Hanff; K Eichelberger; L Longhi; H Teresa; J Pratt; A Cheng; J M Letourneau; G M Thorne
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

4.  Comparison of a dot immunobinding assay, latex agglutination, and cytotoxin assay for laboratory diagnosis of Clostridium difficile-associated diarrhea.

Authors:  G L Woods; P C Iwen
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

5.  Use of non-radioactive DNA probes for detection of Campylobacter jejuni and Campylobacter coli in stool specimens.

Authors:  D E Taylor; K Hiratsuka
Journal:  Mol Cell Probes       Date:  1990-08       Impact factor: 2.365

6.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

Review 7.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

8.  Specific detection of toxigenic strains of Clostridium difficile in stool specimens.

Authors:  P H Gumerlock; Y J Tang; J B Weiss; J Silva
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

9.  Enzyme immunoassay (ELISA) for detection of Clostridium difficile toxin B in specimens of faeces.

Authors:  V K Nguyen; B Rihn; C Heckel; F Bisseret; R Girardot; H Monteil
Journal:  J Med Microbiol       Date:  1990-04       Impact factor: 2.472

10.  Identification of enterotoxigenic Escherichia coli with synthetic alkaline phosphatase-conjugated oligonucleotide DNA probes.

Authors:  J Seriwatana; P Echeverria; D N Taylor; T Sakuldaipeara; S Changchawalit; O Chivoratanond
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.